| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $168.3B | — | $170.7B | — | -1.4% |
| Op. Income | $19.8B | — | $17.0B | — | 16.3% |
| Gross Margin | 44.6% | — | 41.7% | — | 2.9pp |
| Net Margin | 8.5% | — | 7.4% | — | 1.0pp |
| EPS (Diluted) | $6.99 | — | $5.95 | — | 17.5% |
| Free Cash Flow | $22.3B | — | -$26.2B | — | 185.2% |
| Item | Amount |
|---|---|
| REVENUE | $168.3B |
| Cost of Revenue | $93.3B |
| GROSS PROFIT | $75.0B |
| R&D Expenses | $2.3B |
| Selling & Marketing | $1.1B |
| General & Administrative | $38.3B |
| SG&A Expenses | $39.4B |
| Other Expenses | $13.4B |
| Operating Expenses | $55.2B |
| Cost & Expenses | $148.5B |
| OPERATING INCOME | $19.8B |
| Interest Income | $142.9B |
| Interest Expense | $83.1B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $19.8B |
| Income Tax Expense | $5.4B |
| Net Income from Continuing Ops | $14.5B |
| Net Income from Discontinued Ops | -$3M |
| Other Adjustments | -$38M |
| NET INCOME | $14.3B |
| Net Income Deductions | -$36M |
| BOTTOM LINE NET INCOME | $13.1B |
| D&A | $3.3B |
| EBIT | $19.8B |
| EBITDA | $23.1B |
| EPS | $7 |
| EPS Diluted | $7 |
| Item | Amount |
|---|---|
| REVENUE | $168.3B |
| Cost of Revenue | $93.3B |
| GROSS PROFIT | $75.0B |
| R&D Expenses | $2.3B |
| Selling & Marketing | $1.1B |
| General & Administrative | $38.3B |
| SG&A Expenses | $39.4B |
| Other Expenses | $13.4B |
| Operating Expenses | $55.2B |
| Cost & Expenses | $148.5B |
| OPERATING INCOME | $19.8B |
| Interest Income | $142.9B |
| Interest Expense | $83.1B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $19.8B |
| Income Tax Expense | $5.4B |
| Net Income from Continuing Ops | $14.5B |
| Net Income from Discontinued Ops | -$3M |
| Other Adjustments | -$38M |
| NET INCOME | $14.3B |
| Net Income Deductions | -$36M |
| BOTTOM LINE NET INCOME | $13.1B |
| D&A | $3.3B |
| EBIT | $19.8B |
| EBITDA | $23.1B |
| EPS | $7 |
| EPS Diluted | $7 |
| Item | Amount |
|---|---|
| Net Income | $14.1B |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $17.2B |
| Change in Working Capital | -$2.5B |
| OPERATING CASH FLOW | $28.8B |
| Capital Expenditure | -$6.5B |
| Acquisitions (Net) | $62M |
| Purchases of Investments | -$458.2B |
| Sales/Maturities of Investments | $330.2B |
| Other Investing Activities | -$70.3B |
| NET CASH FROM INVESTING | -$204.7B |
| Net Debt Issuance | $115.4B |
| Common Stock Repurchased | -$18.3B |
| Common Dividends Paid | -$5.4B |
| Other Financing Activities | $139.0B |
| NET CASH FROM FINANCING | $238.0B |
| FREE CASH FLOW | $22.3B |
| Net Change in Cash | $0 |
| Item | Amount |
|---|---|
| Cash & Equivalents | $349.6B |
| Short-Term Investments | $325.9B |
| Net Receivables | $62.7B |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $738.1B |
| PP&E (Net) | $33.3B |
| Goodwill | $19.1B |
| Intangible Assets | $4.3B |
| Long-Term Investments | $444.2B |
| Tax Assets | $0 |
| Other Non-Current Assets | $1.4T |
| TOTAL NON-CURRENT ASSETS | $1.9T |
| TOTAL ASSETS | $2.7T |
| Account Payables | $74.8B |
| Short-Term Debt | $400.0B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $1.1T |
| TOTAL CURRENT LIABILITIES | $1.5T |
| Long-Term Debt | $315.8B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $315.8B |
| TOTAL LIABILITIES | $2.4T |
| Common Stock | $31M |
| Additional Paid-In Capital | $108.5B |
| Retained Earnings | $215.1B |
| Treasury Stock | -$89.5B |
| Accum. Other Comp. Income | -$41.9B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $212.3B |
| Minority Interest | $1.5B |
| TOTAL EQUITY | $213.8B |
| TOTAL LIABILITIES & EQUITY | $2.7T |
| Total Debt | $715.8B |
| Net Debt | $366.2B |
